You've tried everything. The drugstore brand. The stronger drugstore brand. Maybe even the prescription. Months in, your toenail still looks like it always did. You're hiding your feet at the pool. Nothing's working.
Worth asking: are you sure it's fungus?
What most people don't realize
Most people treating a toenail for fungus never had it diagnosed. They saw something on their toe, matched a picture online, started buying things. That's how the category works. The packaging shows a bad-looking nail, the product promises to fix it, you fill in the rest.
Here's what the research actually shows. In a 2014 study of 541 toenail clipping samples sent to a Boston hospital lab for testing, doctors got the diagnosis right at very different rates depending on who was doing the looking.1
The doctor you see changes the answer.
% of clinically suspected toenail fungus that lab testing actually confirmed.
Podiatrists
Most accurate. Foot specialists know what fungus does and doesn't look like.
Dermatologists
Strong, but slightly less accurate than podiatrists on toes.
Your regular doctor
Wrong about a third of the time. Most people start here.
Source: Tang et al, Dermatology Research and Practice, 2018. 541 toenail clippings, Brigham and Women's Hospital, 2000-2013.
That last number means roughly one in three diagnoses from your regular doctor is wrong. And those are people who at least got off the couch and saw a doctor. People who diagnose themselves from a Google image search and a CVS aisle, with no exam, no clipping, no lab test, get it wrong even more often than that.
In broader populations of people walking around with damaged-looking toenails, the research suggests the actual fungal rate is closer to half. Half the people with thick, yellow, brittle nails have something other than fungus going on.2
So if you've never had a clipping sent to a lab, there's a real chance, somewhere between 1 in 4 and 1 in 2 depending on the population, that what you've been treating isn't fungus at all.
This matters because no antifungal helps a nail that isn't fungal. The strongest pill, the most expensive prescription brush-on, the most well-reviewed thing on the drugstore shelf. If the underlying problem isn't fungus, none of them are doing anything.
This is the unglamorous truth behind a huge percentage of "I tried everything and nothing worked" stories. The trying happened. It was just aimed at the wrong target.
The numbers nobody prints on the box
Here's what the research says about the products people typically reach for, when fungus is what they're dealing with.
The prescription pill. Oral terbinafine is the strongest commonly-prescribed treatment. The lab test stops finding fungus in 62-78% of patients across most clinical trials, up to 94% in extended courses.3 But "the lab can't find fungus anymore" isn't the same as "the nail looks normal." That second part, what doctors call complete cure, is a much smaller number.
The numbers nobody prints on the box.
Complete cure means the fungus is gone and the nail actually looks normal. Not just one. Both.
Prescription Oral (12-week course)
Terbinafine, big toenail
Terbinafine, all involved nails
Prescription Topical (48-week course, daily)
Efinaconazole 10% solution
Tavaborole 5% solution
Ciclopirox 8% lacquer
Sources: Shemer et al, JEADV 2015. Indian J Dermatol Venereol Leprol, 2015. American Family Physician, 2016. Cochrane Reviews on onychomycosis treatment.
In a 2015 study of 76 patients on terbinafine, complete cure across all the toenails involved was 5-8% after 24 weeks of treatment.4 In another study, complete cure on the big toenail specifically was 23%, with smaller toenails between 51-67%.5
So terbinafine often kills the fungus. But the nail frequently still looks damaged afterward. The damaged appearance is what most people wanted fixed in the first place.
The prescription brush-ons. Efinaconazole, tavaborole, ciclopirox. The FDA-approved paint-on options, applied daily for 48 weeks. Their full-cure rates from the FDA trials are above. Number needed to treat: 7 to 17. Translation: between 7 and 17 people have to use these products daily for almost a year for one of them to fully clear.6
The drugstore aisle. The brush-ons and creams most people start with. Substantially weaker evidence behind any of them. Many of the over-the-counter "nail fungus" products in the US legally can't claim to treat the actual nail at all. Read the small print on the back and most of them quietly disclose that they're for the skin around the nail, not the nail itself.
And then it comes back. Recurrence after successful treatment runs 20-50% within three years across multiple follow-up studies.7 Even the people who win lose again.
These numbers aren't secret. They're sitting in the published research. The packaging just doesn't print them.
of people with damaged-looking toenails have something other than fungus going on.
What looks like fungus, but isn't
If you're in the group whose nail isn't actually fungal, here's what's actually going on instead.
Seven things that look like fungus, but aren't.
A rough field guide. None of these are rare. None of them respond to antifungals.
Trauma
Most likely if
You run, hike, work in boots, play soccer, or wear shoes that don't quite fit.
The tells
Big or second toe. Often one foot only.
Polish damage
Most likely if
Years of dark polish, gels, acrylics, removers.
The tells
Multiple nails. Yellow, brittle, sometimes white-patched.
Age
Most likely if
You're over 60 and the change has been gradual.
The tells
Thickening and ridging, multiple nails, no patch discoloration.
Psoriasis
Most likely if
You have skin psoriasis or family history.
The tells
Pits in the nail surface. Salmon-colored patches.
Pseudomonas
Most likely if
Color is distinctly green or blue-green.
The tells
Bacterial, not fungal. Sometimes a faint sweet smell.
Lichen planus
Most likely if
You have skin or mouth lichen planus.
The tells
Thinning, longitudinal ridging, splitting.
Onycholysis
Most likely if
A recent injury or manicuring incident.
The tells
Lifted nail with debris underneath.
Plus several others
Including
Eczema, contact dermatitis, melanonychia, subungual hematoma.
The point
The list is long. A clinician's exam is the only way to know.
A simplified reference. Definitive diagnosis requires a podiatrist or dermatologist exam, often with a nail clipping sent for lab analysis.
None of these are rare. All of them get treated as fungus by people who don't know there's anything else on the list.
Why a lot of people skip the prescription
For people who do confirm fungus through a podiatrist visit, the conversation usually ends in one of two places: a brush-on prescription you have to apply daily for 48 weeks with cure rates between 7% and 18%, or oral terbinafine.
The pill works for a lot of people. It's also why a lot of people walk out of that appointment without filling the prescription.
The standard course is 250 milligrams a day for 12 weeks. The drug has documented liver toxicity risk. Periodic blood tests are required for many people. It interacts with a long list of common medications, including antidepressants, beta blockers, and certain antibiotics. The FDA label includes warnings about rare but serious liver failure.
For most people considering it for what's essentially a cosmetic concern, the math goes something like this: you're being asked to take a pill with documented liver risk, get bloodwork done, and accept a 35-50% chance of a normal-looking toenail at the end. For something that isn't life-threatening.
A lot of people say no. That's a reasonable call, even if no one in the medical system says it out loud. People who say no to the pill aren't making a mistake. They're doing the math, and for many of them, the math doesn't add up.
The frustrating part is what happens next. Once you've turned down the prescription, the medical system doesn't have much else to offer. The drugstore aisle is full of products that legally can't claim what they imply. The home-remedy world has a few things that work partially. Your social media feeds are full of ads promising results in 14 days that toenail biology makes physically impossible. So you bounce between options, trying everything, blaming yourself when nothing sticks.
Almost none of this gives anyone a clear path forward. Which is part of why this blog post exists.
Why this is the most expensive mistake in the category
What happens to most people: you notice something on a toe. You match a picture online. You buy a drugstore antifungal. It doesn't work. You buy the stronger one. It doesn't work either. After a few months you finally see a doctor. You get a prescription. It might work, it might not. Even if it does, the damaged appearance often persists. So you buy something else for that. That doesn't work either.
If you're in the group with confirmed fungus, you're somewhere between 7% and 78% likely to see actual change depending on which product you're using and how strict the definition of "cure" is. If you're in the group whose nail isn't actually fungal, you've been treating the wrong thing the whole time. Sometimes for years.
Both the drugstore aisle and the prescription pad default to the same answer: antifungal. Neither is set up to ask whether the original assumption was right. Most people never get a clipping sent to a lab. Most never even consider that the assumption itself might be off.
The total cost, across products, prescriptions, doctor visits, time, and the slow erosion of confidence that comes from cycling through things that don't work, ends up being significantly higher than what any of these people would have paid for an actual diagnosis up front.
See a podiatrist before you spend more
If you've been at this for six months without progress, the cheapest move is a real diagnosis. Twenty minutes. A podiatrist looks at your toe. Sometimes they take a clipping for the lab. You walk out actually knowing what you're dealing with.
The visit is often less than the next bottle of something you'd have bought anyway. And it ends the cycle.
We're not a substitute for that visit. If your nail is painful, bleeding, spreading fast, or you have diabetes or circulation issues, a podiatrist is the first stop, not a brush-on.
What consistency actually means
For people who do have a confirmed correct diagnosis, fungal or otherwise, the most common reason any product "doesn't work" isn't the product. It's stopping too early.
Toenails grow about 1 millimeter per month. The visible nail you see today is the nail you'll have for the next several months. There's no product on Earth, drugstore, prescription, or otherwise, that changes that fact. New healthy nail has to grow in from the cuticle and replace the damaged part. That takes 6 to 12 months for the smaller toenails, up to 18 months for the big toe in some people.
The most common pattern in people who say "I tried that product and it didn't work" is four to six weeks of use, no dramatic visible change, giving up. That's not enough time for any topical, prescription or otherwise, to show what it can do. The fungus might already be retreating. The nail might already be growing in cleaner at the cuticle. But the visible part, the part you're judging, is still the old damaged nail. It'll be the old damaged nail for months.
This is true for prescription brush-ons, drugstore antifungals, home remedies, and Veto. None of them are different on this. Skip consistency and nothing else matters.
If you're not willing to use something daily for at least six months, no product in this category is the right product for you. That's not a sales pitch. It's just what toenails do.
Where Veto fits
Veto is a cosmetic. We don't claim to treat fungal infection or any other medical condition. We're not an antifungal. We're regulated as a cosmetic, the same regulatory category as moisturizer or hair conditioner.
What Veto does is help with the appearance of damaged toenails. Discoloration. Brittleness. Dryness. The texture of a nail that's been through years of something.
For nails that aren't fungal at all, the surface still benefits from being looked after. The conditioning oils in Veto, sweet almond, jojoba, vitamin E, improve the appearance of the surface of any damaged nail, regardless of what damaged it. A nail beaten up by running. A nail recovering from years of polish. A psoriatic nail under medical management while new nail grows underneath. The visible part looks better with regular care.
For nails that are fungal and have been treated with a prescription, Veto is built for what comes after. People who've finished a course of terbinafine often have damaged-looking nails that need months to grow out, even though the fungus itself is gone. A daily cosmetic for the visible appearance during that grow-out period is exactly the kind of routine podiatrists typically recommend post-treatment. We can't claim Veto prevents recurrence. We're a cosmetic, not a drug. What we can say is that Veto is designed for daily long-term use and works fine after a prescription course you've already finished.
What Veto won't do is fix the underlying cause if the cause is mechanical or systemic. Marathon shoes will keep traumatizing the nail. Psoriasis needs management from a dermatologist. Heavy polish habits need a polish-free recovery period. Veto helps with the appearance of the visible nail you have right now, while whatever's actually happening sorts out at biology's pace.
For people whose original assumption was fungus and whose real issue turns out to be something else, Veto often makes sense as a daily-use cosmetic for the appearance of the nail itself. Not because it treats the underlying problem. Because the visible nail still benefits from being looked after while the rest sorts out.
The one-bottle rule
If three antifungals haven't worked, the next thing to spend money on is a podiatrist visit. Not a fourth antifungal.
We'd rather you skip Veto entirely and find out from a doctor that you have psoriasis or trauma damage than buy a bottle, find out we're not what you needed either, and add us to the disappointment list.
Not the most aggressive thing a brand can say in a blog post about its own product. It is, however, true.
The category has trained customers to keep buying. We'd rather train customers to know what they're treating before they spend money on treating it.
What honesty looks like in this category
Most of what's wrong with this market is summed up in three words: "results in 14 days."
That phrase, and the dozens of variations on it, is everywhere. It's effective marketing because it tells you what you want to hear. It's also impossible. Toenails grow at one millimeter per month. The visible nail today is the visible nail for the next several months, no matter what you put on it. Anyone who claims to give you a new-looking toenail in 14 days is either selling you a temporary cosmetic gloss, usually some optical brightener, or they're lying. Often both.
The honest version of this category looks different. It tells you the diagnostic uncertainty up front. It cites the actual numbers without cherry-picking the flattering ones. It tells you to see a doctor before you buy anything else. It admits when it isn't the right product for you. It charges you for the timeline that toenails actually need, not for an imagined fast version that doesn't exist.
That version sells fewer first bottles to people who would have given up on it anyway. It also keeps the customers who stay. We've decided that's the right tradeoff.
If you've been correctly diagnosed as fungal, or your podiatrist has confirmed there's no infection to chase and the issue is cosmetic, or you've finished a course of prescription antifungals and want a daily routine for the nail while it grows out, Veto fits. Daily use. Honest timelines. No miracle claims. The rest of the story is on the front page.
If you're not sure which group you're in: see a doctor first.
We'll be here either way.
References
- Tang MM, Corti MA, Stirnimann R, et al. Clinical Diagnostic Accuracy of Onychomycosis: A Multispecialty Comparison Study. Dermatology Research and Practice, 2018. Brigham and Women's Department of Dermatopathology, 541 toenail clippings, 2000-2013.
- Multiple sources cite a 50% rate of confirmed onychomycosis in all-comers with onychodystrophy as a working clinical estimate. Accuracy of clinical diagnosis varies significantly by specialist type and population studied.
- Cochrane Reviews on onychomycosis treatment; multiple meta-analyses. Mycological cure rates with continuous oral terbinafine 250mg/day for 12-16 weeks consistently report 62-78% across major trials, with rates up to 94% in extended protocols.
- Indian Journal of Dermatology, Venereology and Leprology, 2015. Comparative efficacy of continuous and pulse dose terbinafine in toenail dermatophytosis. Complete cure rates of 5.3-7.9% across all involved nails at 24 weeks.
- Shemer A, Sakka N, Trau H. Clinical comparison and complete cure rates of terbinafine efficacy in affected onychomycotic toenails. Journal of the European Academy of Dermatology and Venereology, 2015. Big toe complete cure 23%, second toe 65%, third toe 51%, fourth toe 67%.
- American Family Physician, 2016. Topical Antifungals for Treatment of Onychomycosis. Citing FDA pivotal trials for efinaconazole 10% solution (complete cure 15-18%), tavaborole 5% solution (6.5-9.1%), and ciclopirox 8% lacquer (7%). Number needed to treat: 7-17.
- Multiple longitudinal studies. Onychomycosis recurrence and reinfection rates of 20-50% within 3 years are well-documented in the dermatology and podiatry literature.


